Cash flow Netcare Limited

Stocks

NTC

ZAE000011953

Healthcare Facilities & Services

End-of-day quote Johannesburg S.E. Other stock markets 2026-07-13			5-day change	1st Jan Change
18.88 ^ZAR	+1.51%		+2.00%	+19.27%

05-25	Netcare Limited, H1 2026 Earnings Call, May 25, 2026
05-25	Netcare Limited Reports Earnings Results for the Half Year Ended March 31, 2026	CI

62be92a1.p5AtwtiNHPSlY81tFmeDsODmMxFzg2lysWzTXQbnJXs.6_Nfhqz3VY36BvgIVT7JhIukWVQ-4SxCxi6QHjCDVA3e2myd9cxuo-YB_Q

Published financial data: NETCARE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	21.2B	21.64B	23.7B	25.2B	26.34B
Total Revenues	21.2B	21.64B	23.7B	25.2B	26.34B
Cost of Goods Sold, Total	10.75B	11.08B	11.94B	12.75B	13.25B
Gross Profit	10.45B	10.55B	11.76B	12.46B	13.09B
Selling General & Admin Expenses, Total	8.5B	8.57B	9.31B	9.7B	10.1B
Provision for Bad Debts	-	-	-	205M	198M
Other Operating Expenses	-142M	-255M	-325M	-546M	-718M
Other Operating Expenses, Total	8.36B	8.31B	8.98B	9.36B	9.58B
Operating Income	2.09B	2.24B	2.78B	3.1B	3.52B
Interest Expense, Total	-845M	-828M	-1B	-1.21B	-1.16B
Interest And Investment Income	116M	115M	144M	205M	133M
Net Interest Expenses	-729M	-713M	-858M	-1B	-1.03B
Income (Loss) On Equity Invest.	-114M	21M	40M	51M	70M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-1M	0	2M	-8M	-11M
EBT, Excl. Unusual Items	1.25B	1.54B	1.96B	2.14B	2.55B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-31M	-	-26M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-73M	-11M	-125M	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	1.18B	1.53B	1.81B	2.14B	2.52B
Income Tax Expense	416M	484M	471M	591M	713M
Earnings From Continuing Operations	760M	1.05B	1.34B	1.55B	1.81B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	760M	1.05B	1.34B	1.55B	1.81B
Minority Interest	9M	-37M	-15M	-48M	-67M
Net Income - (IS)	769M	1.01B	1.32B	1.5B	1.74B
Preferred Dividend and Other Adjustments	39M	38M	64M	87M	87M
Net Income to Common Incl Extra Items	730M	975M	1.26B	1.41B	1.66B
Net Income to Common Excl. Extra Items	730M	975M	1.26B	1.41B	1.66B
Per Share Items
Net EPS - Basic	0.55	0.73	0.95	1.1	1.35
Basic EPS - Continuing Operations	0.55	0.73	0.95	1.1	1.35
Basic Weighted Average Shares Outstanding	1.34B	1.34B	1.33B	1.28B	1.22B
Net EPS - Diluted	0.54	0.72	0.94	1.09	1.33
Diluted EPS - Continuing Operations	0.54	0.72	0.94	1.09	1.33
Diluted Weighted Average Shares Outstanding	1.34B	1.35B	1.34B	1.3B	1.25B
Normalized Basic EPS	0.59	0.69	0.91	1.01	1.25
Normalized Diluted EPS	0.59	0.69	0.9	0.99	1.22
Dividend Per Share	0.34	0.5	0.65	0.7	0.85
Payout Ratio	-	71.87	61.17	56.7	54.91
American Depositary Receipts Ratio (ADR)	10	10	10	10	10
Supplemental Items
EBITDA	2.87B	2.99B	3.58B	3.92B	4.34B
EBITA	2.09B	2.24B	2.78B	3.1B	3.52B
EBIT	2.09B	2.24B	2.78B	3.1B	3.52B
EBITDAR	3.06B	3.18B	3.76B	4.07B	4.48B
Effective Tax Rate - (Ratio)	35.37	31.55	26.07	27.64	28.26
Current Domestic Taxes	-	556M	361M	378M	737M
Current Foreign Taxes	-	-	4M	4M	2M
Total Current Taxes	-	556M	365M	382M	739M
Deferred Domestic Taxes	-	-76M	104M	209M	-26M
Deferred Foreign Taxes	-	4M	-	-	-
Total Deferred Taxes	-	-72M	104M	209M	-26M
Normalized Net Income	790M	929M	1.21B	1.29B	1.53B
Interest Capitalized	-	24M	17M	25M	25M
Interest on Long-Term Debt	655M	719M	910M	1.02B	1.05B
Non-Cash Pension Expense	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	8.44B	8.51B	9.25B	9.64B	10.04B
Research And Development Expense From Footnotes	-	2M	2M	-	-
Net Rental Expense, Total	184M	190M	173M	145M	137M
Imputed Operating Lease Interest Expense	109M	119M	122M	114M	101M
Imputed Operating Lease Depreciation	74.9M	70.89M	51.22M	30.53M	35.59M
Stock-Based Comp., Other (Total)	-	41M	98M	130M	124M
Total Stock-Based Compensation	-	41M	98M	130M	124M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.46B	1.5B	2.28B	1.8B	1.89B
Short Term Investments	-	2M	15M	17M	-
Trading Asset Securities, Total	4M	-	-	-	-
Total Cash And Short Term Investments	1.46B	1.5B	2.29B	1.82B	1.89B
Accounts Receivable, Total	3.25B	2.86B	3.54B	3.44B	3.38B
Other Receivables	112M	331M	9M	413M	505M
Notes Receivable	132M	59M	27M	22M	43M
Total Receivables	3.5B	3.25B	3.58B	3.88B	3.93B
Inventory	640M	562M	556M	550M	520M
Prepaid Expenses	-	116M	-	119M	136M
Other Current Assets, Total	-	6M	-	15M	30M
Total Current Assets	5.6B	5.44B	6.43B	6.38B	6.51B
Gross Property Plant And Equipment	-	22.95B	23.99B	24.94B	25.81B
Accumulated Depreciation	-	-5.71B	-6.03B	-6.1B	-6.49B
Net Property Plant And Equipment	16.52B	17.24B	17.96B	18.83B	19.32B
Long-term Investments	487M	517M	446M	441M	475M
Goodwill	1.61B	1.61B	1.61B	1.61B	1.68B
Other Intangibles, Total	200M	205M	187M	214M	377M
Loans Receivable Long-Term	219M	176M	223M	129M	61M
Deferred Tax Assets Long-Term	987M	1.04B	854M	668M	733M
Deferred Charges Long-Term	-	32M	80M	100M	78M
Other Long-Term Assets, Total	12M	17M	19M	20M	1M
Total Assets	25.62B	26.27B	27.8B	28.39B	29.22B
Liabilities
Accounts Payable, Total	3.21B	1.32B	1.29B	1.31B	1.48B
Accrued Expenses, Total	-	1.61B	1.79B	1.73B	1.97B
Short-term Borrowings	-	4M	1M	-	-
Current Portion of Long-Term Debt	1.85B	1.11B	1.25B	1.6B	562M
Current Portion of Leases	508M	582M	658M	731M	731M
Current Income Taxes Payable	18M	49M	26M	129M	93M
Other Current Liabilities	38M	609M	587M	762M	812M
Total Current Liabilities	5.62B	5.28B	5.6B	6.26B	5.65B
Long-Term Debt	4.94B	5.26B	6.06B	5.5B	6.8B
Long-Term Leases	3.59B	3.91B	4.33B	4.81B	4.87B
Pension & Other Post Retirement Benefits	503M	533M	495M	526M	534M
Deferred Tax Liability Non Current	309M	319M	254M	265M	325M
Other Non Current Liabilities	74M	22M	19M	50M	57M
Total Liabilities	15.03B	15.33B	16.76B	17.42B	18.24B
Preferred Stock Non Redeemable	644M	3M	3M	3M	3M
Preferred Stock - Others	-	641M	641M	641M	641M
Total Preferred Equity	644M	644M	644M	644M	644M
Common Stock, Total	4.3B	4.3B	4.3B	4.23B	4.08B
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	8.78B	8.98B	9.48B	9.8B	9.97B
Treasury Stock	-3.56B	-3.5B	-3.93B	-4.31B	-4.4B
Comprehensive Income and Other	413M	473M	526M	563M	576M
Total Common Equity	9.93B	10.25B	10.38B	10.29B	10.23B
Minority Interest	12M	54M	21M	39M	117M
Total Equity	10.59B	10.94B	11.04B	10.97B	10.99B
Total Liabilities And Equity	25.62B	26.27B	27.8B	28.39B	29.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.34B	1.34B	1.31B	1.25B	1.19B
ECS Total Common Shares Outstanding	1.34B	1.34B	1.31B	1.25B	1.19B
Book Value / Share	7.43	7.66	7.95	8.24	8.58
Tangible Book Value	8.13B	8.44B	8.58B	8.47B	8.17B
Tangible Book Value Per Share	6.08	6.3	6.57	6.79	6.86
Total Debt	10.88B	10.86B	12.3B	12.65B	12.96B
Net Debt	9.42B	9.36B	10B	10.83B	11.08B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	1.47B	1.52B	1.38B	1.16B	1.1B
Minority Interest, Total (Incl. Fin. Div)	12M	54M	21M	39M	117M
Equity Method Investments, Total	424M	418M	383M	415M	421M
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	-	106M	122M	198M	168M
Inventories - Finished Goods, Total	-	351M	434M	352M	352M
Inventories - Others	-	105M	-	-	-
Land - (BS)	-	12.2B	12.45B	13B	13.41B
Machinery, Total	-	6.67B	7.04B	7.14B	7.53B
Full Time Employees	-	-	18K	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	375M	-	397M	463M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	769M	1.01B	1.32B	1.5B	1.74B
Depreciation & Amortization - CF	1.16B	1.16B	1.23B	1.29B	1.29B
Amortization of Goodwill and Intangible Assets - (CF)	-	3M	4M	3M	3M
Depreciation & Amortization, Total	1.16B	1.16B	1.23B	1.29B	1.29B
Amortization of Deferred Charges, Total - (CF)	-	36M	40M	39M	59M
Minority Interest in Earnings - (CF)	-19M	-25M	-47M	-50M	-57M
(Gain) Loss From Sale Of Asset	-	11M	-14M	0	29M
(Gain) Loss on Sale of Investments - (CF)	-	50M	13M	-1M	-13M
Asset Writedown & Restructuring Costs	-	11M	130M	38M	30M
Provision for Credit Losses	-	18M	29M	5M	13M
Stock-Based Compensation (CF)	-	41M	98M	130M	124M
Provision and Write-off of Bad Debts	-	112M	114M	205M	198M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	398M	-43M	2M	4M	-320M
Change In Accounts Receivable	-	-114M	-361M	-512M	-183M
Change In Inventories	-	79M	6M	6M	30M
Change In Accounts Payable	-	273M	133M	63M	457M
Change in Other Net Operating Assets	-	-11M	-8M	-	-
Cash from Operations	2.3B	2.61B	2.69B	2.72B	3.4B
Capital Expenditure	-1.13B	-1.38B	-1.44B	-1.46B	-1.5B
Sale of Property, Plant, and Equipment	36M	35M	101M	40M	35M
Cash Acquisitions	-	-	-	-	-54M
Divestitures	-	-	-	-	-1M
Sale (Purchase) of Intangible assets	-12M	-14M	-64M	-56M	-127M
Investment in Marketable and Equity Securities, Total	-126M	-21M	-90M	92M	-11M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	208M	134M	190M	233M	193M
Cash from Investing	-1.03B	-1.25B	-1.31B	-1.15B	-1.47B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	1B	1.9B	2.08B	2.6B	2.15B
Total Debt Issued	1B	1.9B	2.08B	2.6B	2.15B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.28B	-2.5B	-1.4B	-3.07B	-2.18B
Total Debt Repaid	-2.28B	-2.5B	-1.4B	-3.07B	-2.18B
Issuance of Common Stock	1M	29M	49M	-	-
Repurchase of Common Stock	-	-29M	-510M	-722M	-855M
Common Dividends Paid	-	-728M	-808M	-850M	-957M
Common & Preferred Stock Dividends Paid	-	-728M	-808M	-850M	-957M
Other Financing Activities, Total	8M	2M	-10M	3M	-11M
Cash from Financing	-1.27B	-1.32B	-599M	-2.04B	-1.85B
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	10M	39M	783M	-476M	87M
Supplemental Items
Cash Interest Paid	812M	828M	970M	1.19B	1.18B
Cash Income Tax Paid (Refund)	618M	439M	374M	345M	758M
Levered Free Cash Flow	1.12B	1.25B	883M	929M	1.69B
Unlevered Free Cash Flow	1.64B	1.76B	1.51B	1.68B	2.42B
Change In Net Working Capital	-322M	-524M	91M	195M	-373M
Net Debt Issued / Repaid	-1.28B	-599M	680M	-472M	-26M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.07	5.39	6.42	6.89	7.63
Return on Total Capital	6.06	6.46	7.69	8.24	9.24
Return On Equity %	7.46	9.75	12.15	14.06	16.48
Return on Common Equity	7.66	9.66	12.19	13.67	16.14
Margin Analysis
Gross Profit Margin %	49.3	48.77	49.63	49.42	49.7
SG&A Margin	40.1	39.61	39.28	38.49	38.33
EBITDA Margin %	13.55	13.81	15.12	15.57	16.49
EBITA Margin %	9.87	10.35	11.74	12.3	13.36
EBIT Margin %	9.87	10.34	11.73	12.28	13.35
Income From Continuing Operations Margin %	3.58	4.85	5.64	6.14	6.87
Net Income Margin %	3.63	4.68	5.57	5.95	6.62
Net Avail. For Common Margin %	3.44	4.51	5.3	5.6	6.29
Normalized Net Income Margin	3.72	4.29	5.11	5.11	5.79
Levered Free Cash Flow Margin	5.26	5.76	3.72	3.69	6.43
Unlevered Free Cash Flow Margin	7.75	8.15	6.37	6.68	9.18
Asset Turnover
Asset Turnover	0.82	0.83	0.88	0.9	0.91
Fixed Assets Turnover	1.29	1.28	1.35	1.37	1.38
Receivables Turnover (Average Receivables)	6.67	7.66	7.4	7.77	7.72
Inventory Turnover (Average Inventory)	11.64	18.44	21.35	23.05	24.77
Short Term Liquidity
Current Ratio	1	1.03	1.15	1.02	1.15
Quick Ratio	0.86	0.89	1.04	0.91	1.02
Operating Cash Flow to Current Liabilities	0.41	0.49	0.48	0.43	0.6
Days Sales Outstanding (Average Receivables)	54.69	47.67	49.32	47.07	47.29
Days Outstanding Inventory (Average Inventory)	31.34	19.79	17.09	15.88	14.74
Average Days Payable Outstanding	115.38	39.79	39.97	37.29	38.47
Cash Conversion Cycle (Average Days)	-29.34	27.66	26.45	25.67	23.56
Long Term Solvency
Total Debt/Equity	102.78	99.26	111.39	115.28	117.99
Total Debt / Total Capital	50.68	49.81	52.69	53.55	54.13
LT Debt/Equity	80.5	83.8	94.11	94.01	106.22
Long-Term Debt / Total Capital	39.7	42.06	44.52	43.67	48.73
Total Liabilities / Total Assets	58.67	58.34	60.29	61.35	62.4
EBIT / Interest Expense	2.48	2.7	2.77	2.57	3.03
EBITDA / Interest Expense	3.85	4.1	4	3.64	4.15
(EBITDA - Capex) / Interest Expense	2.51	2.43	2.56	2.43	2.85
Total Debt / EBITDA	3.35	3.2	3.07	2.88	2.69
Net Debt / EBITDA	2.9	2.76	2.49	2.47	2.3
Total Debt / (EBITDA - Capex)	5.14	5.39	4.79	4.32	3.92
Net Debt / (EBITDA - Capex)	4.45	4.64	3.9	3.7	3.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.51	2.06	9.54	6.34	4.53
Gross Profit, 1 Yr. Growth %	15.71	0.95	11.48	6.14	5.12
EBITDA, 1 Yr. Growth %	34.65	4.7	19.91	13.5	10.68
EBITA, 1 Yr. Growth %	55.27	6.92	24.24	16.59	13.58
EBIT, 1 Yr. Growth %	55.27	6.88	24.23	16.65	13.6
Earnings From Cont. Operations, 1 Yr. Growth %	73.12	38.16	27.24	15.79	17
Net Income, 1 Yr. Growth %	72.42	31.73	30.4	13.47	16.28
Normalized Net Income, 1 Yr. Growth %	121.57	17.6	30.5	13.63	18.46
Diluted EPS Before Extra, 1 Yr. Growth %	93.24	32.04	30.4	16.47	22.04
Accounts Receivable, 1 Yr. Growth %	4.8	2.69	23.72	13.33	-1.77
Inventory, 1 Yr. Growth %	-46.93	-12.19	-1.07	-1.08	-5.45
Net Property, Plant and Equip., 1 Yr. Growth %	0.58	4.38	4.18	4.85	2.58
Total Assets, 1 Yr. Growth %	-1.24	2.53	5.84	2.11	2.94
Tangible Book Value, 1 Yr. Growth %	11.04	2.69	1.75	-1.33	-3.5
Common Equity, 1 Yr. Growth %	8.88	3.15	1.27	-0.84	-0.6
Cash From Operations, 1 Yr. Growth %	-1.85K	13.32	2.91	1.15	25.19
Capital Expenditures, 1 Yr. Growth %	17.79	22.08	4.41	1.39	2.73
Levered Free Cash Flow, 1 Yr. Growth %	-678.84	9.26	-29.2	15.42	82.2
Unlevered Free Cash Flow, 1 Yr. Growth %	281.68	5.69	-14.47	17.63	43.68
Dividend Per Share, 1 Yr. Growth %	-	47.06	30	7.69	21.43
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.9	7.16	5.73	7.93	5.43
Gross Profit, 2 Yr. CAGR %	-2.24	8.08	6.08	8.65	5.63
EBITDA, 2 Yr. CAGR %	-19.71	18.36	12.05	14.61	12.08
EBITA, 2 Yr. CAGR %	-24.97	28.91	15.26	17.62	15.08
EBIT, 2 Yr. CAGR %	-24.95	28.82	15.23	17.64	15.12
Earnings From Cont. Operations, 2 Yr. CAGR %	-44.62	54.65	32.59	21.38	16.4
Net Income, 2 Yr. CAGR %	-43.94	50.71	31.07	21.65	14.87
Normalized Net Income, 2 Yr. CAGR %	-39.33	61.42	23.88	17.78	16.02
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.3	59.74	31.22	23.24	19.22
Accounts Receivable, 2 Yr. CAGR %	17.57	-3.93	12.71	9.68	5.51
Inventory, 2 Yr. CAGR %	6.52	-31.74	-6.79	-1.07	-3.29
Net Property, Plant and Equip., 2 Yr. CAGR %	14.76	2.46	4.28	4.52	3.71
Total Assets, 2 Yr. CAGR %	9.38	0.63	4.17	3.96	2.53
Tangible Book Value, 2 Yr. CAGR %	1.94	7.35	2.22	0.2	-2.42
Common Equity, 2 Yr. CAGR %	2.04	5.98	2.21	0.21	-0.72
Cash From Operations, 2 Yr. CAGR %	-15.37	344.84	7.99	2.03	12.53
Capital Expenditures, 2 Yr. CAGR %	-9.36	19.92	12.9	2.89	2.06
Levered Free Cash Flow, 2 Yr. CAGR %	-20.56	154.4	-12.05	-13.66	45.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12.45	102.43	-4.92	-2.33	30
Dividend Per Share, 2 Yr. CAGR %	-44.66	-	38.27	18.32	14.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.77	0.07	7.94	5.93	6.78
Gross Profit, 3 Yr. CAGR %	0.32	-1.19	9.2	6.02	7.46
EBITDA, 3 Yr. CAGR %	-13.02	-12.47	18.87	11.21	13.28
EBITA, 3 Yr. CAGR %	-15.34	-15.54	27.33	13.94	16.26
EBIT, 3 Yr. CAGR %	-15.3	-15.56	27.27	13.94	16.28
Earnings From Cont. Operations, 3 Yr. CAGR %	-8.92	-24.89	44.92	26.73	19.9
Net Income, 3 Yr. CAGR %	-46.21	-25.47	43.61	24.92	19.83
Normalized Net Income, 3 Yr. CAGR %	-29.16	-24.35	50.38	17.72	18.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-12.96	-25.73	49.29	26.11	22.84
Accounts Receivable, 3 Yr. CAGR %	12.62	6.77	4.52	7.3	5.72
Inventory, 3 Yr. CAGR %	2.81	-0.12	-22.75	-4.93	-2.56
Net Property, Plant and Equip., 3 Yr. CAGR %	10.93	11.19	3.03	4.47	3.87
Total Assets, 3 Yr. CAGR %	7.26	7.05	2.33	3.48	3.62
Tangible Book Value, 3 Yr. CAGR %	0.49	2.55	5.45	1.02	-1.05
Common Equity, 3 Yr. CAGR %	0.72	2.41	4.38	1.18	-0.06
Cash From Operations, 3 Yr. CAGR %	-2.45	-6.72	173.08	5.66	9.23
Capital Expenditures, 3 Yr. CAGR %	-9.2	0.1	14.51	8.93	2.84
Levered Free Cash Flow, 3 Yr. CAGR %	70.58	-10.97	66.09	-6.61	10.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	42.56	-6.29	51.9	0.28	11.08
Dividend Per Share, 3 Yr. CAGR %	-31.11	-23.34	-	27.22	19.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-10.89	2.51	2.73	3.14	6.93
Gross Profit, 5 Yr. CAGR %	-8.66	2.22	2.58	2.64	7.71
EBITDA, 5 Yr. CAGR %	-11.61	-7.91	-3.87	-2.5	15.29
EBITA, 5 Yr. CAGR %	-12.3	-7.43	-4.2	-3.58	21.16
EBIT, 5 Yr. CAGR %	-12.28	-7.44	-4.21	-3.58	21.14
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.97	-16.18	5.84	-8.99	32.75
Net Income, 5 Yr. CAGR %	-14.86	15.49	-23.19	-9.34	31.34
Normalized Net Income, 5 Yr. CAGR %	-15.53	-26.35	-11.41	-9.7	33.76
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.61	-26.85	2.58	-9.05	36.45
Accounts Receivable, 5 Yr. CAGR %	-2.28	-3.39	9.25	7.93	1.75
Inventory, 5 Yr. CAGR %	-8.88	-10.6	-1.15	-0.5	-15.49
Net Property, Plant and Equip., 5 Yr. CAGR %	2.75	4.39	8.22	8.47	3.3
Total Assets, 5 Yr. CAGR %	-3.53	-1.35	6.01	5.8	2.41
Tangible Book Value, 5 Yr. CAGR %	6.43	6.1	1.4	1.6	2.23
Common Equity, 5 Yr. CAGR %	-0.48	4.35	1.31	1.53	2.31
Cash From Operations, 5 Yr. CAGR %	-8.11	0.71	1.6	-3.31	91.55
Capital Expenditures, 5 Yr. CAGR %	-16.5	-10.59	-0.93	1.2	9.36
Levered Free Cash Flow, 5 Yr. CAGR %	12.86	4.57	31.48	-12.06	54.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.75	6.66	21.62	-4.72	41.22
Dividend Per Share, 5 Yr. CAGR %	-18.58	-12.05	-8.97	-8.81	-